- Graves disease is an autoimmune disorder that causes hyperthyroidism by overstimulating the thyroid gland. The treatment options include anti-thyroid medications, radioactive iodine therapy, and surgery, which aim to reduce thyroid hormone production.
- The demand for Graves disease treatment is significantly driven by the rising number of thyroid disorder cases, improved diagnostic capabilities, and increasing availability of treatment options globally.
- North America dominates the Graves disease treatment market due to high healthcare spending, early diagnosis rates, and robust reimbursement frameworks.
- Asia-Pacific is anticipated to witness the fastest growth due to increasing healthcare access and awareness campaigns in countries like China and India.
- Anti-thyroid drugs are expected to hold the largest market share of 41.32% in 2025 due to their effectiveness as a first-line treatment option. Increased preference for non-invasive therapies and wide availability are expected to drive segment growth.
